Agilent, GKSP-318, AdvanceBio APTS G2FGa2 / FA2G2Ga(3)2 N-glycan Standard

AdvanceBio APTS G2FGa2 / FA2G2Ga(3)2 N-glycan Standard. N-glycan (asialo-, galactosylated, biantennary, core-substituted with fucose and with 2 α(1,3) galactose) labeled with 8-aminopyrene-1,3,6-trisulfonate (APTS) for use in applications such as capillary electrophoresis (CE). Alternative glycan names: G2F with 2 alpha gal, F(6)A2G(4)2Ga(3)2, NA2Ga2F.

Specifications:
Chemical Structure:
Label: APTS
Monoisotopic Mass: MWGlycan + 440.9647 = 2551.7204
Name: G2FGa2
Oxford Name: F(6)A2G(4)2Ga(3)2
Standard Type: Complex-type Native N-Glycan
Unit: 60 pmol

**********The following product description is generated by AI and is for reference only. If you have any questions, please contact customer service.**********
This high-purity N-glycan standard is specifically designed for reliable characterization and quantitation in biopharmaceutical research and quality control. It contains defined APTS-labeled G2FGa2 and FA2G2Ga(3)2 N-glycan structures, enabling advanced profiling of glycosylation patterns from monoclonal antibodies and other glycoproteins. Its consistent performance supports use as a reference during method development, system suitability testing, and routine glycan analysis. Optimized for seamless integration with Agilent’s AdvanceBio Glycan Mapping solutions, it is fully compatible with HPLC, UHPLC, and capillary electrophoresis platforms equipped with fluorescence detection. Researchers working on biosimilar characterization, lot-to-lot comparability studies, or glycan structure verification will benefit from this standard’s accuracy and traceability. It ensures confidence in data integrity when confirming glycan migration times, retention profiles, and peak identification. Suitable for use alongside other AdvanceBio Glycan Standards and consumables, this product streamlines assay development and enhances comparability across analytical batches. Packaged for laboratory convenience, it saves valuable sample preparation time while minimizing sources of variability in complex glycomic workflows. This standard supports regulatory compliance and robust glycoprotein analysis in both research and regulated environments.